FRIDAY, Nov. 1, 2024 -- The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who...
Vous n'êtes pas connecté
MONDAY, Sept. 9, 2024 -- A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the weekly injections they now take, a new study demonstrates. The new formulation encases semaglutide in...
FRIDAY, Nov. 1, 2024 -- The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who...
FRIDAY, Nov. 1, 2024 -- The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who...
THURSDAY, Oct. 24, 2024 -- Add Alzheimer’s disease to the list of conditions that might benefit from the revolutionary diabetes drug Ozempic, a new...
MONDAY, Oct. 28, 2024 -- The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows. Patients taking semaglutide...
The airline SAS announced in a press release on Wednesday that it will open a new route from Copenhagen to Nuuk in Greenland on 27 June 2025.There...
THURSDAY, Oct. 31, 2024 -- For individuals with obesity and knee osteoarthritis, once-weekly semaglutide yields greater reductions in body weight and...
Continued research from the FWPA-supported National Centre for Timber Durability and Design Life (NCTDDL) is seeking to address the fire risks...
A flexible silicone ring that slowly releases antiretrovirals is one of just two long-acting HIV prevention products registered for use in South...
Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A study published in...
Among the 14,409 new passenger cars that were registered in October, more than 60 percent were electric cars. This is a new record for the highest...